CSGCX
Price
$45.93
Change
-$0.07 (-0.15%)
Updated
Sep 16 closing price
Net Assets
1.44B
RLBFX
Price
$38.69
Change
-$0.01 (-0.03%)
Updated
Sep 16 closing price
Net Assets
263.25B
Interact to see
Advertisement

CSGCX vs RLBFX

Header iconCSGCX vs RLBFX Comparison
Open Charts CSGCX vs RLBFXBanner chart's image
Calvert Balanced C
Price$45.93
Change-$0.07 (-0.15%)
VolumeN/A
Net Assets1.44B
American Funds American Balanced R5
Price$38.69
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets263.25B
CSGCX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSGCX vs. RLBFX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 263B vs. CSGCX (1.44B). RLBFX pays higher dividends than CSGCX: RLBFX (2.05) vs CSGCX (0.64). CSGCX was incepted earlier than RLBFX: CSGCX (32 years) vs RLBFX (23 years). CSGCX (1.66) is less costly to investors than RLBFX (0.29). CSGCX is a more actively managed with annual turnover of: 153.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than CSGCX: RLBFX (250) vs CSGCX (1000). RLBFX annual gain was more profitable for investors over the last year : 9.77 vs. CSGCX (6.16). RLBFX return over 5 years is better than : 44.27 vs. CSGCX (33.20).
CSGCXRLBFXCSGCX / RLBFX
Total Expense Ratio1.660.29572%
Annual Report Gross Expense Ratio1.660.29572%
Fund Existence32 years23 years-
Gain YTD8.50813.34964%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B263B1%
Annual Yield % from dividends0.642.0531%
Returns for 1 year6.169.7763%
Returns for 3 years40.1944.3891%
Returns for 5 years33.2044.2775%
Returns for 10 years56.2382.5568%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRCT39.571.57
+4.13%
PROCEPT BioRobotics Corp
RDY14.730.10
+0.68%
Dr. Reddy's Laboratories Ltd
ASPC10.34N/A
N/A
A Spac III Acquisition Corp
EQV10.38-0.01
-0.10%
EQV Ventures Acquisition Corp
RKDA3.42-0.03
-1.01%
Arcadia Biosciences